Hermann and coworkers explored the immunophenotypic features of CD34+/CD38− cells purified from a large set of AML and CML patients and observed that CD123, as well as CD33, are clearly more expressed on leukemic cells compared to the normal CD34+/CD38− counterpart [30]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.